Enhanced fungal DNA-extraction from formalin-fixed, paraffin-embedded tissue specimens by application of thermal

Volker Rickerts1, Prasanna D Khot, Daisy L Ko

  • 1Robert Koch Institut, Berlin, Germany. RickertsV@rki.de

Medical Mycology
|March 15, 2012
PubMed

Insights

Optimizing DNA extraction using heat improves the detection of fungal DNA in tissue samples. This enhanced method aids in identifying the cause of invasive fungal infections (IFI) for better patient treatment.

Area of Science:

  • Medical Mycology
  • Molecular Diagnostics
  • Pathology

Background:

  • Accurate diagnosis of invasive fungal infections (IFI) is crucial for effective antifungal therapy.
  • Culture methods often yield negative results, obscuring the etiology of IFI.
  • Molecular methods like PCR offer an alternative but are limited by DNA degradation in fixed tissues.

Purpose of the Study:

  • To investigate the impact of thermal energy during DNA extraction on the yield of amplifiable fungal DNA from formalin-fixed, paraffin-embedded (FFPE) tissues.
  • To enhance the identification of fungal species in FFPE samples for improved IFI diagnostics.

Main Methods:

  • Real-time PCR was used to quantify human and fungal DNA in FFPE tissue sections from eight patients with proven IFI.
  • DNA extraction protocols were modified with varying incubation temperatures (65°C to 90°C) and durations (up to 6 hours).
  • Sequencing of PCR amplicons was performed to identify fungal species.

Main Results:

  • Increasing incubation temperature from 65°C to 90°C increased amplifiable DNA yield by up to 76-fold.
  • Extended incubation up to 6 hours at 90°C further augmented DNA amplification.
  • Improved fungal DNA amplification correlated with enhanced species identification through sequencing.

Conclusions:

  • Optimizing thermal conditions during DNA extraction significantly enhances fungal DNA recovery from FFPE tissues.
  • This improved molecular approach can help determine the etiology of IFI, even with challenging samples.
  • Accurate etiological diagnosis through enhanced PCR and sequencing can guide antifungal therapy and improve patient management.